FDA approves new HPV vaccination
COLUMBIA - The FDA approved an update to Gardasil 9, the HPV vaccine this week. The new vaccine prevents nine types of HPV, while the original Gardasil, approved in 2006, prevented four types.
The additional types are not common among those who are diagnosed with cancer, but are common among those who experience genital warts.
A study including 14,000 women taking Gardasil 9 resulted in a 97 percent effectiveness for HPV causing cancers, according to the FDA. The previous vaccine prevented a reported 70 percent of cancers.
The HPV vaccine in general has been controversial since before it was first approved. Critics complained about the side effects, which include depression, blood clots, headaches and nausea. There have been some reports of infertility.
KOMU 8 News wants your opinion on the vaccine. Please participate in our poll.